Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
When the manufacturer's validation isn't enough
A manufacturer's performance data may not fully apply when your laboratory changes how an IVD is used.
For example, you may be:
In these situations, your laboratory needs to consider what evidence is required for your specific intended use.
This is a content preview space you can use to get your audience interested in what you have to say so they can’t wait to learn and read more. Pull out the most interesting detail that appears on the page and write it here.

The structure and content of ISO 15189:2022 have been revised.
For IQC Standards 7.3.7.2 focus is on specifications based on the intended clinical application of the examination.

The IQC section has been expanded from three subclauses to seven (a-g) where ‘a’ is defined as:
a1) The intended clinical application of the examination should be considered, as the performance specifications for the same measurand can differ in different clinical settings.

When designing an appropriate QC strategy several risk factors need to be taken into consideration:


Manufactured based on the intended clinical application specifications of the examination to monitor.
They are designed to deliver an unbiased and independent assessment of performance with any instrument or method, enabling laboratories to gain accreditation and ensure optimum performance and accuracy in clinical laboratory.

Embed Third party controls in clinical testing to cover critical decision points to avoid testing accreditation noncompliance.
Remember, IQC is not just about compliance; it is about managing quality effectively. Implementing correct levels of IQC in a medical laboratory is essential to ensure accurate and reliable test results.

ISO 15189 specifically focuses on the unique requirements of medical laboratories and the significance should not be underestimated, especially in the field of public health. ISO 15189 was fundamentally revised at the end of 2022. It sets out more detailed requirements and emphasizes the importance of risk management even more strongly. Furthermore Vitro Diagnostic Medical Devices regulation (IVDR) now makes concrete demands on laboratories. A lot of medical laboratories are not fully aware of the existing and the new requirements. Lets review some of the main points:
In-house IVD: What are they? An IVD is “a laboratory developed test (LDT) that is designed, manufactured and used within a single laboratory or within health institutions established in the Union”. This includes any device used to examine or monitor humans, including “software or systems” connected to in vitro activity.
A medical laboratory can also create CE Marked devices to an LDT by:
What are Legal requirements for IVDR?
Laboratories must develop, manufacture and surveil their own Laboratory Developed Tests (largely) in conformity with the requirements of the IVDR depending on a product’s risk classification. There are four categories (A to D) with A representing the lowest risk and D the highest.
The use of commercially available IVD devices is preferred and laboratories can only offer their own LDTs if the devices on the market do not meet the required performance.
Your next steps as a medical laboratory?
Let us work out the evidence you need.
Tell us what you've developed, modified or implemented — and where you're currently stuck.
7.0 Product realisation
7.3 Design and development
7.3.2 Design and development planning
Method Comparison and Bias Estimation Using Patient Samples
7.3.3 Requirements for Quality and Compliance and manufacturing process”
Join us and discover what we can do for you.
Precision
How consistently does the method produce results?
Accuracy / Trueness
How close are results to an appropriate reference or comparator?
Analytical Measurement Range
Across what range can the method provide reliable results?
Linearity
Does the method respond appropriately across the intended measuring range?
Detection Capability
Can the method reliably detect clinically relevant levels?
Analytical Specificity
Does the assay measure the intended target without significant interference?
Interference
Could endogenous or exogenous substances affect results?
Reproducibility
Does performance remain consistent across relevant operators, runs, instruments or time periods?
A method can perform well analytically and still require careful consideration of its clinical application.
Depending on the test, this may involve evaluation of:
New In-Vitro Diagnostics Regulation(IVDR) and ISO 15189, 2022 introduces new compliance challenges for manufacturers and testing laboratories using in-house devices
IVDR now makes concrete demands on laboratories using any laboratory developed test. A lot of medical laboratories are not fully aware of the existing and the new requirements
With a rapidly changing world of therapeutics a lot of devices do not have
clinical performance studies or clinical testing to correlate with the products stated 'intended use' provided with the IVD technical documentation
Verification process delays with Clinical laboratories trying to achieve ISO accreditation leaving new and better devices out of clinical use.
Pathology organizations adopting a multi-site hub and spoke model introduces new implementation challenges for laboratory management

Send us your data and we will analyse the data and compile the report to ISO 15189 requirements.

Review and or audit your processes before and perform gap analysis for ISO 15189 accreditation.

Full assay/instrument implementation;
From planning and testing to full report write up. This is the hassle free product for the entire process enabling you to concrete on your day to day activities.

With our expert guidance, navigate the complexities of ISO 15189 and IVDR regulations to ensure your diagnostic devise meets the highest standards of quality and compliance.